Published in Gene Therapy Weekly, February 3rd, 2005
BIO represents more than 1,000 member organizations across 3 major areas of research and development: healthcare, food and agriculture, and industrial and environmental biotechnology. Carl B. Feldbaum, president of BIO from its inception in 1993, has retired.
"The biotechnology industry is dedicated to solving humanity's toughest problems; it's creating cures for heartbreaking diseases, improved crops for better nutrition, and clean biofuels for a better environment," said Greenwood. "In 2004, the industry delivered on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.